angiotensin ii has been researched along with cyclin d1 in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 16 (51.61) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Albanese, C; Batlle, D; Lee, RJ; Pestell, RG; Rainey, WE; Watanabe, G | 1 |
| Bottari, SP; Bourmeyster, N; Chambaz, EM; Defaye, G; Liakos, P | 1 |
| Bereziat, G; Guillemot, L; Levy, A; Rothhut, B; Zhao, ZJ | 1 |
| Bassett, M; Batlle, D; Francis, R; Harirchian, S; Mayhew, B; Pestell, RG; Rainey, WE; Wang, C | 1 |
| Guillemot, L; Levy, A; Raymondjean, M; Rothhut, B | 1 |
| Bartek, J; Bartkova, J; Busk, PK; Christoffersen, TE; Haunsø, S; Hinrichsen, R; Latella, L; Sheikh, SP; Strøm, CC; Wulf-Andersen, L | 1 |
| Morita, H; Sabbah, HN; Sharov, VG; Suzuki, G; Tanhehco, EJ; Todor, A | 1 |
| Blaschke, F; Bruemmer, D; Kintscher, U; Law, RE; Unger, T | 1 |
| Garnovskaya, MN; Grewal, JS; Mukhin, YV; Raymond, JR; Tholanikunnel, BG; Ullian, ME; Vlasova, TM | 1 |
| Hou, YZ; Yang, J; Yuan, YJ; Zhao, GR | 1 |
| Adachi, S; Isobe, M; Ito, H; Kitajima, S; Maejima, Y; Morikawa-Futamatsu, K; Suzuki, J; Tamamori-Adachi, M | 1 |
| Chen, Y; Gao, F; Huang, Z; Liu, Q; Shi, G; Wang, J; Zhang, Y; Zheng, J; Zhou, Y | 1 |
| Dong, LH; Han, M; Liu, Y; Wen, JK; Zheng, B | 1 |
| He, SY; Qian, ZY; Xiang, M; Zhou, CH | 1 |
| Doller, A; Eberhardt, W; Pfeilschifter, J; Schlepckow, K; Schwalbe, H | 1 |
| Cai, L; Chen, X; Fu, S; Sui, G; Yang, Y; Zhao, Y | 1 |
| Chen, MS; He, YH; Hou, N; Huang, Y; Luo, JD; Luo, MS; Wu, JH; Xiao, Q; Yi, Q; Zhang, GP; Zhang, GS; Zhang, HN | 1 |
| Du, N; Feng, J; Hu, LJ; Ren, H; Sun, HB; Sun, X; Yang, YP; Zhao, Y | 1 |
| Bu, P; Cui, L; Hou, X; Liu, T; Shen, YH; Song, S; Zhang, Y | 1 |
| Akhtar, J; Bing, C; Che, Y; Qiang, W; Rong, W; Ruiyu, Z; Yi, L | 1 |
| Choi, E; Ham, O; Hwang, KC; Kim, MH; Lee, CY; Lee, J; Lee, SY; Min, PK; Park, JH; Seo, HH; Seung, M | 1 |
| Cuevas, CA; Gonzalez, AA; Inestrosa, NC; Prieto, MC; Vio, CP | 1 |
| Dong, X; Gao, D; Hao, G; Liu, Z; Meng, Z; Ning, N; Niu, X; Yang, G | 1 |
| Cespedes, C; Cuevas, CA; Inestrosa, NC; Tapia-Rojas, C; Vio, CP | 1 |
| Chen, H; Fan, Y; Han, Y; Li, X; Pei, X | 1 |
| Domińska, K; Kowalska, K; Matysiak-Burzyńska, Z; Nowakowska, M; Piastowska-Ciesielska, AW; Płuciennik, E | 1 |
| Lu, H; Lu, J; Xu, F; Zhang, J; Zhang, Y | 1 |
| Budhram-Mahadeo, VS; Clark, JE; Heads, RJ; Maskell, LJ; Mele, L; Stuckey, DJ | 1 |
| Chen, X; Gu, J; Ling, S; Liu, M; Liu, N; Liu, S; Liu, X; Ou, W; Xu, Q; Zhang, F | 1 |
| Jeong, MH; Kee, HJ; Kee, SJ; Kim, GR; Zhao, T | 1 |
| Han, Y; Liu, D; Liu, Y; Tian, X; Yan, C; Zhang, X | 1 |
31 other study(ies) available for angiotensin ii and cyclin d1
| Article | Year |
|---|---|
Angiotensin II activation of cyclin D1-dependent kinase activity.
Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Cyclin D1; Cyclin-Dependent Kinases; Cyclins; Enzyme Activation; Flow Cytometry; G1 Phase; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Oncogene Proteins; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Proto-Oncogene Proteins p21(ras); RNA, Messenger; Xenopus | 1996 |
ANG II AT1 and AT2 receptors both inhibit bFGF-induced proliferation of bovine adrenocortical cells.
Topics: Adrenal Cortex; Angiotensin II; Animals; Cattle; Cell Cycle; Cell Division; Cells, Cultured; Cyclin D1; Dinoprostone; Fibroblast Growth Factor 2; G1 Phase; Imidazoles; Indomethacin; Oligopeptides; Prostaglandin D2; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 1997 |
The protein-tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHO-AT1A cells.
Topics: Angiotensin II; Animals; Catalysis; CHO Cells; Cricetinae; Cyclin D1; G1 Phase; Gene Expression Regulation; Humans; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-raf; Proto-Oncogene Proteins p21(ras); Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; S Phase; SH2 Domain-Containing Protein Tyrosine Phosphatases; src Homology Domains; Transcriptional Activation | 2000 |
The application of high density microarray for analysis of mitogenic signaling and cell-cycle in the adrenal.
Topics: Adrenal Cortex; Angiotensin II; Cell Cycle; Cell Cycle Proteins; Cell Line; Cyclin D1; Humans; Mitogens; Oligonucleotide Array Sequence Analysis; Signal Transduction | 2000 |
Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT(1A) cells.
Topics: Androstadienes; Angiotensin II; Animals; Binding Sites; Butadienes; Cell Line; Cell Nucleus; CHO Cells; Cricetinae; Cyclin D1; DNA Mutational Analysis; DNA-Binding Proteins; Early Growth Response Protein 1; Enzyme Inhibitors; Genes, Dominant; Humans; Immediate-Early Proteins; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mutagenesis, Site-Directed; Nitriles; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; Protein Binding; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Transcription Factors; Transcriptional Activation; Transfection; Tyrosine; Up-Regulation; Wortmannin | 2001 |
Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro.
Topics: Angiotensin II; Animals; Blotting, Western; Caenorhabditis elegans Proteins; Carrier Proteins; Cells, Cultured; Cyclin D1; Cyclin D2; Cyclin D3; Cyclin-Dependent Kinases; Cyclins; Helminth Proteins; Hypertrophy, Left Ventricular; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction | 2002 |
Hypoxia, angiotensin-II, and norepinephrine mediated apoptosis is stimulus specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and cyclin D1.
Topics: Angiotensin II; Animals; Apoptosis; Cyclin D1; Disease Models, Animal; Dogs; Fas Ligand Protein; Follow-Up Studies; Heart Failure; Hypoxia; Incidence; Membrane Glycoproteins; Mitogen-Activated Protein Kinases; Models, Cardiovascular; Myocytes, Cardiac; Norepinephrine; p38 Mitogen-Activated Protein Kinases | 2003 |
p38 MAP kinase negatively regulates angiotensin II-mediated effects on cell cycle molecules in human coronary smooth muscle cells.
Topics: Angiotensin II; Cell Cycle; Cells, Cultured; Cyclin D1; DNA; Enzyme Inhibitors; Humans; Imidazoles; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Retinoblastoma Protein; Thiazoles | 2003 |
Mitogen-induced rapid phosphorylation of serine 795 of the retinoblastoma gene product in vascular smooth muscle cells involves ERK activation.
Topics: Androstadienes; Angiotensin II; Animals; Aorta; Blotting, Western; Cell Membrane; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Immunoblotting; Mitogen-Activated Protein Kinases; Mitogens; Models, Biological; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Precipitin Tests; Proto-Oncogene Proteins; Rats; Retinoblastoma Protein; Serine; Serotonin; Time Factors; Wortmannin | 2004 |
Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II.
Topics: Angiotensin II; Animals; Blotting, Western; Cell Cycle Proteins; Cell Proliferation; Cells, Cultured; Coumaric Acids; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme Activation; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Retinoblastoma Protein | 2004 |
HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Topics: Adenoviridae Infections; Amides; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Cyclin D1; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Indoles; Intracellular Signaling Peptides and Proteins; Leucine; Male; Mevalonic Acid; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger | 2006 |
N-4-tert-butyl benzyl haloperidol chloride suppresses Ca2+-dependent Egr-1 expression and subsequently inhibits vascular smooth muscle cell proliferation induced by angiotensin II.
Topics: Angiotensin II; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Proliferation; Cells, Cultured; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Early Growth Response Protein 1; G1 Phase; Haloperidol; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley | 2009 |
Krüppel-like factor (KLF) 5 mediates cyclin D1 expression and cell proliferation via interaction with c-Jun in Ang II-induced VSMCs.
Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Cyclin D1; Flow Cytometry; Gene Expression Regulation; Kruppel-Like Transcription Factors; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription, Genetic | 2010 |
Crocetin inhibits cell cycle G1/S transition through suppressing cyclin D1 and elevating p27kip1 in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Carotenoids; Cattle; Cell Cycle; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Vitamin A | 2010 |
Tandem phosphorylation of serines 221 and 318 by protein kinase Cdelta coordinates mRNA binding and nucleocytoplasmic shuttling of HuR.
Topics: Angiotensin II; Antigens, Surface; Cell Line; Cell Movement; Cell Nucleus; Cyclin A; Cyclin D1; ELAV Proteins; ELAV-Like Protein 1; Gene Expression Regulation; Humans; Intracellular Space; Phosphorylation; Phosphoserine; Point Mutation; Protein Binding; Protein Kinase C-delta; Protein Transport; Regulatory Sequences, Ribonucleic Acid; RNA-Binding Proteins; RNA, Messenger; Time Factors | 2010 |
Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromones; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Imidazoles; Losartan; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Receptor, Angiotensin, Type 1; Signal Transduction; Vasoconstrictor Agents | 2010 |
A physiological concentration of glucocorticoid inhibits the pro-inflammatory cytokine-induced proliferation of adult rat cardiac fibroblasts: roles of extracellular signal-regulated kinase 1/2 and nuclear factor-κB.
Topics: Angiotensin II; Animals; Cell Growth Processes; Cells, Cultured; Cyclin D1; Hydrocortisone; Inflammation; Inflammation Mediators; Interleukin-1beta; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardium; Myofibroblasts; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation | 2011 |
Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; CREB-Binding Protein; Cyclin D1; Female; Humans; Irbesartan; Mitogen-Activated Protein Kinases; NF-kappa B; Proliferating Cell Nuclear Antigen; raf Kinases; ras Proteins; Receptor, Angiotensin, Type 1; RNA Interference; RNA, Small Interfering; Signal Transduction; Tetrazoles; Tumor Suppressor Protein p53 | 2012 |
PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.
Topics: Angiotensin II; Animals; Cell Differentiation; Cell Proliferation; Cell Survival; Collagen Type I; Collagen Type III; Cyclin D1; Fibroblasts; JNK Mitogen-Activated Protein Kinases; Myocardium; Myofibroblasts; Phenotype; PPAR gamma; Protein Multimerization; Protein Structure, Quaternary; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription Factor AP-1; Transforming Growth Factor beta1 | 2013 |
AngiotensinII induces HuR shuttling by post-transcriptional regulated CyclinD1 in human mesangial cells.
Topics: Angiotensin II; Cells, Cultured; Cyclin D1; ELAV Proteins; Gene Expression Regulation; Humans; Mesangial Cells; RNA-Binding Proteins; RNA, Messenger | 2014 |
MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1.
Topics: Angiotensin II; Animals; Atherosclerosis; Becaplermin; Carotid Arteries; Carotid Artery Injuries; Cell Division; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclin D1; Down-Regulation; MicroRNAs; Muscle, Smooth, Vascular; Neointima; Proliferating Cell Nuclear Antigen; Protein Binding; Proto-Oncogene Proteins c-sis; Rats; RNA-Binding Proteins; S Phase Cell Cycle Checkpoints | 2014 |
Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cells.
Topics: Actins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; beta Catenin; Cell Line; Collagen Type I; Cyclin D1; Fibronectins; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Kidney Tubules, Collecting; Mice; Myofibroblasts; Phenotype; Phosphorylation; Proto-Oncogene Proteins c-myc; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Time Factors; Up-Regulation | 2015 |
Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells.
Topics: Angiotensin II; Anilides; Animals; Blood Pressure; Body Weight; Cell Proliferation; Cells, Cultured; Cyclin D1; Gene Expression Regulation; Hypoglycemic Agents; Kruppel-Like Transcription Factors; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; PPAR gamma; Prostaglandin D2; Protein Kinase C; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2015 |
β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats.
Topics: Angiotensin II; Animals; beta Catenin; Blood Pressure; Cyclin D1; Fibrosis; Humans; Hypertension; Kidney; Kidney Diseases; Lisinopril; Proto-Oncogene Proteins c-myc; Pyrvinium Compounds; Rats; Signal Transduction | 2015 |
Thymoquinone Inhibits Angiotensin II-Induced Proliferation and Migration of Vascular Smooth Muscle Cells Through the AMPK/PPARγ/PGC-1α Pathway.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Benzoquinones; Cell Cycle; Cell Movement; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Gene Expression Regulation; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase | 2016 |
Angiotensin II promotes endometrial cancer cell survival.
Topics: Angiotensin II; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin E; Endometrial Neoplasms; Female; Gene Expression; Humans; Oncogene Proteins; Signal Transduction | 2016 |
ClC-2 knockdown prevents cerebrovascular remodeling via inhibition of the Wnt/β-catenin signaling pathway.
Topics: Angiotensin II; Animals; Basilar Artery; beta Catenin; Cell Movement; Cell Proliferation; Chloride Channels; CLC-2 Chloride Channels; Cyclin D1; Glycogen Synthase Kinase 3 beta; Humans; Ion Transport; Male; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; RNA Interference; RNA, Small Interfering; Vascular Remodeling; Wnt Signaling Pathway | 2018 |
The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart.
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; bcl-2-Associated X Protein; Calcineurin; Cardiovascular Diseases; Cyclin D1; Gene Expression Regulation; Glucose Transporter Type 4; Humans; Hypertrophy; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Primary Cell Culture; Rats; RNA, Small Interfering; Transcription Factor Brn-3B | 2019 |
Ubiquitin-specific protease 2 regulates Ang Ⅱ-induced cardiac fibroblasts activation by up-regulating cyclin D1 and stabilizing β-catenin in vitro.
Topics: Angiotensin II; Animals; Animals, Newborn; beta Catenin; Cell Adhesion Molecules; Cell Cycle; Cell Movement; Cell Proliferation; Collagen Type III; Connective Tissue Growth Factor; Cyclin D1; Fibroblasts; Muscle Proteins; Myocardium; Protein Stability; Rats, Sprague-Dawley; Ubiquitin; Ubiquitin Thiolesterase; Up-Regulation; Wnt Signaling Pathway | 2021 |
MicroRNA-212-5p and its target PAFAH1B2 suppress vascular proliferation and contraction via the downregulation of RhoA.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Angiotensin II; Animals; Antagomirs; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclin D1; Disease Models, Animal; Down-Regulation; Hypertension; MicroRNAs; Muscle Contraction; Muscle, Smooth, Vascular; Rats; rhoA GTP-Binding Protein; RNA Interference; RNA, Small Interfering; Vascular Remodeling | 2021 |
RelB represses miR-193a-5p expression to promote the phenotypic transformation of vascular smooth muscle cells in aortic aneurysm.
Topics: Adult; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Cell Movement; Cell Proliferation; Cyclin D1; Cyclin E; Down-Regulation; Female; Humans; Male; Mice; MicroRNAs; Muscle, Smooth, Vascular; Receptors, CXCR4; Transcription Factor RelB | 2023 |